共 50 条
Choice and Timing of Antithrombotic after Ischemic Stroke, Intracerebral Hemorrhage or Cerebral Venous Thrombosis
被引:0
|作者:
Ryan, Dylan
[1
]
Girotra, Tarun
[2
]
Feng, Wuwei
[1
]
机构:
[1] Duke Univ, Dept Neurol, Sch Med, Durham, NC 27512 USA
[2] Univ New Mexico, Dept Neurol, Sch Med, Albuquerque, NM 87106 USA
关键词:
Antithrombotic;
ischemic stroke;
intracerebral hemorrhage;
cerebral venous thrombosis;
anticoagulation;
stroke;
DIRECT ORAL ANTICOAGULANTS;
MOLECULAR-WEIGHT HEPARIN;
ATRIAL APPENDAGE CLOSURE;
HEALTH-CARE PROFESSIONALS;
DUAL ANTIPLATELET THERAPY;
PLACEBO-CONTROLLED TRIAL;
HIGH-RISK PATIENTS;
INTRACRANIAL HEMORRHAGE;
CARDIOEMBOLIC STROKE;
SECONDARY PREVENTION;
D O I:
10.2174/1871527322666230309100626
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Stroke is a multifactorial vascular disease and remains a leading cause of disability in the United States. Strokes can be ischemic or hemorrhagic in nature and secondary to arterial or venous disease, making determining the etiology and secondary prevention strategy important for preservation of the injured brain, prevention of recurrent strokes, and in the maintenance of good functional outcomes for patients impacted by stroke. In this narrative review, we provide a synopsis of the available medical evidence surround selection, timing, and choice of therapy, including utilization of left atrial appendage closure, in patients with ischemic, hemorrhagic or venous stroke.
引用
收藏
页码:135 / 152
页数:18
相关论文